High Throughput Screening Market To Reach $41.67 Billion By 2030

High Throughput Screening Market Growth & Trends

The global high throughput screening market size is expected to reach USD 41.67 billion by 2030, registering a CAGR of 10.6% from 2024 to 2030, according to a new report by Grand View Research, Inc. Increasing adoption of faster and accurate technology by pharmaceutical companies to introduce newer molecules in the market is anticipated to provide a significant push to the market.

High throughput screening is used for testing of molecules in development phase on various grounds such as chemical, pharmaceutical, and genetic reactions. These screenings help in drug design and development based on real-time results and near-natural conditions that mimic natural reactions between the molecule and the body.

Moreover, this method can be fully automated using the required hardware and software capable of handling a fully automated process along with data storage units that store and process a considerable amount of data in a short span of time.

As of 2016, approximately 55.0% of high throughput screening tests are carried out based on the cell-based assays. Cell-based assays are used majorly owing to the results that can be obtained at cellular levels along with pathways and mechanisms.

These assays range from cytotoxic tests, including apoptosis, to cell metabolic assays. One more major technology implantation is the introduction of 3D - cell culture, which can help mimic natural conditions that give more accurate results and reactions to tests carried on. This trend is estimated to support the growth of the market during the forecast period.

 Request a free sample copy or view report summary: High Throughput Screening Market Report

High Throughput Screening Market Report Highlights

• The market is driven by increasing competition between pharmaceutical companies to introduce novel molecules

• Emerging 3D cell culture technology that provides better results in real-time is set to boost the market

• North America emerged as the clear hotspot for the development and adoption of this technology and had a major share in the market

• Emerging regions such as Asia Pacific and Latin America are set to witness considerable growth in demand over the forecast period driven by the need of newer molecules to cure various diseases

High Throughput Screening Market Segmentation

Grand View Research has segmented the global high throughput screening market based on product and services, technology, application, end use, and region:

Products and Services Outlook (Revenue, USD Billion, 2018 - 2030)

• Consumables

  • Reagents & Assay Kits

  • Laboratory Equipment

• Instruments

  • Liquid Handling Systems

  • Detection Systems

  • Other Instruments

• Services

• Software

Technology Outlook (Revenue, USD Billion, 2018 - 2030)

• Cell-based Assays

  • Fluorometric Imaging Plate Reader Assays

  • Reporter based Assays

  • 3D - Cell Cultures

  • 2D - Cell Cultures

  • Reporter-based Assays

  • Perfusion Cell Culture

• Lab-on-a-chip Technology (LOC)

• Label-free Technology

• Ultra High Throughput Screening

Application Outlook (Revenue, USD Billion, 2018 - 2030)

• Drug Discovery Programs

• Chemical Biology Programs

• Biochemical Screening

• Cell & Organ-based Screening

End Use Outlook (Revenue, USD Billion, 2018 - 2030)

• Pharmaceutical & Biopharmaceutical Companies

• Academic & Research Institutes

• Contract Research Organizations (CROs)

• Others

Regional Outlook (Revenue, USD Billion, 2018 - 2030)

• North America

  • U.S.

  • Canada

  • Mexico

• Europe

  • Germany

  • UK

  • France

  • Italy

  • Spain

  • Denmark

  • Sweden

  • Norway

• Asia Pacific

  • China

  • Japan

  • India

  • South Korea

  • Australia

  • Thailand

• Latin America

  • Brazil

  • Argentina

• Middle East and Africa (MEA)

  • Saudi Arabia

  • UAE

  • South Africa

  • Kuwait

List of Key Players in the High Throughput Screening Market

• Agilent Technologies, Inc.

• Danaher Corporation

• Thermo Fisher Scientific Inc.

• PerkinElmer Inc.

• Bio-Rad Laboratories, Inc

• Aurora Biomed Inc.

• Tecan Trading AG

• Promega Corporation

• Charles River Laboratories.

• Creative Biolabs.